• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

IsZo Capital & Black Horse Write to Taro Pharmaceutical Demanding Information Relating to Sun Pharmaceutical Going Private, Squeeze-Out Merger


News provided by

IsZo Capital Management LP

Aug 31, 2012, 10:28 ET

Share this article

Share this article


NEW YORK, Aug. 31, 2012 /PRNewswire/ -- IsZo Capital Management LP and Black Horse Capital Advisors LLC, two of the largest minority shareholders of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), announced today that they delivered the following letter to Taro exercising their respective legal rights under Israeli law to demand certain information relating to the approval by Taro's Board of Directors, Special Committee and Audit Committee of the Agreement of Merger, dated as of August 12, 2012, by which Sun Pharmaceutical Industries Ltd. (BSE: SUNPHARMA), Taro's controlling shareholder, proposes to take Taro private and squeeze out Taro's minority shareholders.

August 31, 2012

VIA COURIER
Taro Pharmaceutical Industries Ltd.
Euro Park (Italy Building)
Yakum Business Park, Yakum 60972, Israel
Attention: General Counsel

Re: Pending Sun/Taro Going Private, Squeeze-Out Merger

       IsZo Capital Letters dated November 29, 2011, December 13, 2011,
       December 23, 2011, February 15, 2012 and May 10, 2012

Ladies and Gentlemen:                                                          

IsZo Capital Management LP ("IsZo") and Black Horse Capital Advisors LLC ("Black Horse"), two of Taro's largest minority shareholders, write to you as follows:

1.  On August 13, 2012, Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") announced that it had entered into an Agreement of Merger, dated as of August 12, 2012 (the "Merger Agreement"), with Sun Pharmaceutical Industries Ltd. and certain of its affiliates ("Sun"), pursuant to which it is intended that a wholly owned subsidiary of Sun merge with and into Taro (the "Merger"), whereupon Taro will become a private company, wholly owned by Sun, and its shares will cease to be traded on the New York Stock Exchange (the "NYSE"). The purpose of the Merger is for Sun, Taro's controlling shareholder, to squeeze out Taro's minority shareholders and acquire Taro's remaining share capital not already owned by Sun at the bargain price of $39.5 per share.

2.  We would like to remind Taro that Sun's previous inadequate and opportunistic offer to purchase the minority shares of Taro for $24.5 per share (the "Previous Offer") was rejected by Taro's Special Committee, which was formed to evaluate the Previous Offer, ten months after the date on which the Previous Offer was first disclosed publicly.

Remarkably, in contrast to the protracted delay by Taro's Special Committee in determining that the Previous Offer was grossly inadequate, substantially undervalued Taro and was clearly deserving of rejection, Taro's Special Committee, Audit Committee and Board of Directors moved quickly to approve the Merger Agreement, under which it is proposed that Taro be taken private by its controlling shareholder and its minority shareholders be squeezed out at what appears to be an egregiously inadequate price, only three weeks after the Previous Offer was rejected by the Special Committee. 

These actions raise serious concerns about the process conducted by Taro's Special Committee, Audit Committee and Board of Directors in connection with the Merger, including questions relating to the (a) information examined and discussions held by Taro's Special Committee, Audit Committee and Board of Directors prior to the approval of the Merger Agreement, (b) compliance by Taro with the U.S. disclosure requirements that apply to it as a public company with shares traded on the NYSE and (c) exercise of fiduciary duties by Taro's directors for the benefit of Taro's minority shareholders, as required by law.

3.  In accordance with Sections 184(3) and 185(a)(1) of the Companies Law, 1999 (the "Companies Law"), as shareholders of the Company, IsZo and Black Horse have the right to review each document relating to acts or transactions that are required to be approved in accordance with the provisions of Section 275 of the Companies Law.

Accordingly, as the consummation of the Merger requires the approval of Taro's shareholders pursuant to the provisions of Section 275 of the Companies Law, as Taro shareholders we have the right to review each document relating to the Merger.  This includes, for the avoidance of doubt, any document relating to the Previous Offer, as the Previous Offer set the stage for the discussions conducted between Sun and Taro with respect to the Merger, as well as any document (including proxies, powers of attorney and voting cards, in each case, whether submitted electronically or in physical form, as well as copies of the Related Documentation (as such term is defined in the letters, dated February 12, 2012 and April 3, 2012, sent by our counsel on our behalf to Taro's counsel)) relating to voting at the Company's 2011 General Meeting (the "2011 General Meeting"), at which Taro's shareholders allegedly approved the grant of indemnification, insurance and exculpation protections to Taro's directors and officers, including for violations in connection with a merger or other going private transaction.  

4.0  In light of the foregoing, pursuant to Sections 184(3) and 185(a)(1) of the Companies Law, we demand that Taro provide us, within seven days from the date of this letter, copies of each document relating to the Merger, the Previous Offer and the 2011 General Meeting, including and without derogating from the generality of the foregoing, the following documents and information (the "Related Documents"):

4.1.  The minutes of all meetings of Taro's Board of Directors, Audit Committee and/or Special Committee, in which the agenda included the discussion and/or approval of the Merger and/or the Previous Offer.

4.2.  All schedules (including disclosure schedules) and exhibits to the Merger Agreement and any confidentiality agreements, exclusivity agreements, voting agreements, side letters and any other ancillary agreements relating to the Merger Agreement.

4.3.  All materials (including background materials) prepared, presented or conveyed in any manner to Taro's Board of Directors, Audit Committee and/or Special Committee with respect to the Merger and/or the Previous Offer, including financial valuations, fairness opinions, financial projections (including pro forma reports), legal opinions (including, for the avoidance of doubt, any legal opinion relating to the obligation of Taro to file publicly any reports with respect to the Merger and the Previous Offer), any information upon which Taro's management has based its repeated assertions that Taro's financial performance is not or is not likely to be sustainable and any other information relevant to the decision of Taro's Board of Directors, Audit Committee and Special Committee to recommend the Merger to Taro's minority shareholders, including any information and documents prepared or furnished by the advisors and legal counsel to the Special Committee, including Citigroup Global Markets Inc., Goldfarb Seligman & Co and Willkie Farr & Gallagher LLP. 

4.4.  Taro's current registry of shareholders and the most up to date list of Taro's shareholders in its possession.

4.5.  A list of shareholders of Taro with respect to which Taro and/or any of its directors and/or officers is aware of any "personal interest" (as defined in the Companies Law) that any such shareholders may have in the proposed Merger.

4.6.  All benefit plans, option agreements, warrants and any other compensation agreements, arrangements or understandings between Taro and its directors and officers, including a description of all other benefits granted to Taro's directors and officers that will take effect if the Merger is consummated. 

5.    We are exercising our legal right as shareholders of Taro to review all of the relevant information in connection with the Merger and the Previous Offer in order to ensure that we make an informed decision as shareholders at the Company's Shareholders Meeting, which will be convened to vote upon the Merger.

6.    Please send copies of all Related Documents to our counsel at Herzog Fox & Neeman copied to this letter below.

7.    This letter does not derogate or exhaust any of our rights, including the right to assert a claim for any damages or seek any fees and costs we may sustain or incur, including attorneys' fees, in enforcing our legal rights as Taro shareholders.

Sincerely,

/s/ Brian Sheehy                                            
Brian Sheehy
Managing Partner
IsZo Capital Management LP

/s/ Dale Chappell
Dale Chappell
Managing Partner
Black Horse Capital Advisors LLC

  

SOURCE IsZo Capital Management LP

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.